This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Oomen, C. M. Articles by Kromhout, D. Search for Related Content PubMed PubMed Citation Articles by Oomen, C. M. Articles by Kromhout, D. Related Collections Nutrition Primary prevention Epidemiology Coronary circulation Endothelium/vascular type/nitric oxide

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2000;20:2134.)
© 2000 American Heart Association, Inc.

Atherosclerosis and Lipoproteins

Arginine Intake and Risk of Coronary Heart Disease Mortality in Elderly Men

Claudia M. Oomen; Marjan J. van Erk; Edith J. M. Feskens; Frans J. Kok; Daan Kromhout

From the Department of Chronic Diseases Epidemiology (C.M.O., E.J.M.F.) and the Division of Public Health Research (D.K.), National Institute of Public Health and the Environment, Bilthoven, the Netherlands, and the Department of Human Nutrition and Epidemiology (C.M.O., M.J.v.E., F.J.K.), Wageningen University, Wageningen, the Netherlands.

Correspondence to Claudia M. Oomen, MSc, Department of Chronic Diseases Epidemiology, National Institute of Public Health and the Environment, Antonie van Leeuwenhoeklaan 9, PO Box 1, 3720 BA Bilthoven, Netherlands. E-mail claudia.oomen{at}rivm.nl

Abstract—From experimental studies, the hypothesis is derived that the amino acid arginine, the precursor of NO, could restore the impaired endothelial function and increased platelet activation observed in atherosclerosis. We investigated whether dietary intake of arginine is associated with reduced coronary heart disease risk in elderly persons. The study population consisted of 806 men aged 64 to 84 years at baseline who participated in the Zutphen Elderly Study, a population-based cohort followed up for 10 years. Information about habitual food consumption was collected by use of the cross-check dietary history method. Ninety (11.2%) of the 806 men died from coronary heart disease. Mean±SD baseline arginine intake was 4.35±1.07 g/d. Meat was the main source of arginine intake (37.1%), followed by bread (13.1%) and milk and milk products (12.1%). Arginine intake was not associated with coronary heart disease mortality. After adjustment for age, the relative risk (RR) for the medium tertile of arginine intake was 0.72 (95% CI 0.44 to 1.18), and the RR for the highest tertile was 0.71 (95% CI 0.43 to 1.19, P for trend=0.19) compared with the lowest tertile of arginine intake. After additional adjustment for history of coronary heart disease and diabetes mellitus, energy intake, body mass index, smoking habit, physical activity, and other relevant dietary and biological risk factors, the RR was 1.86 (95% CI 1.06 to 3.27) for the medium intake and 1.56 (95% CI 0.83 to 2.93) for the highest intake (P for trend=0.17). These results do not support the hypothesis that dietary arginine intake lowers the risk of coronary heart disease mortality.

Key Words: arginine • diet • coronary heart disease • elderly • epidemiology

This article has been cited by other articles:

				Z. Yang and X.-F. Ming Recent advances in understanding endothelial dysfunction in atherosclerosis. Clin. Med. Res., March 1, 2006; 4(1): 53 - 65. [Abstract] [Full Text] [PDF]

				L. M. Bevers, B. Braam, J. A. Post, A. J. van Zonneveld, T. J. Rabelink, H. A. Koomans, M. C. Verhaar, and J. A. Joles Tetrahydrobiopterin, but Not L-Arginine, Decreases NO Synthase Uncoupling in Cells Expressing High Levels of Endothelial NO Synthase Hypertension, January 1, 2006; 47(1): 87 - 94. [Abstract] [Full Text] [PDF]

				S. G. West, A. Likos-Krick, P. Brown, and F. Mariotti Oral L-Arginine Improves Hemodynamic Responses to Stress and Reduces Plasma Homocysteine in Hypercholesterolemic Men J. Nutr., February 1, 2005; 135(2): 212 - 217. [Abstract] [Full Text] [PDF]

				H. L. Gornik and M. A. Creager Arginine and Endothelial and Vascular Health J. Nutr., October 1, 2004; 134(10): 2880S - 2887S. [Abstract] [Full Text] [PDF]

				B. L. Goodwin, L. P. Solomonson, and D. C. Eichler Argininosuccinate Synthase Expression Is Required to Maintain Nitric Oxide Production and Cell Viability in Aortic Endothelial Cells J. Biol. Chem., April 30, 2004; 279(18): 18353 - 18360. [Abstract] [Full Text] [PDF]

				J. P. Cooke, K. Sydow, J. Chen, and P. Huang A Peculiar Result and a Fanciful Hypothesis Regarding L-Arginine * Arterioscler Thromb Vasc Biol, June 1, 2003; 23(6): 1128 - 1128. [Full Text] [PDF]

				J. Loscalzo L-Arginine in Atherosclerosis: Consequences of Methylation Stress in a Complex Catabolism? Arterioscler Thromb Vasc Biol, January 1, 2003; 23(1): 3 - 5. [Full Text] [PDF]

				J. Chen, P. Kuhlencordt, F. Urano, H. Ichinose, J. Astern, and P. L. Huang L-Arginine on Atherosclerosis in ApoE Knockout and ApoE/Inducible NO Synthase Double-Knockout Mice Arterioscler Thromb Vasc Biol, January 1, 2003; 23(1): 97 - 103. [Abstract] [Full Text] [PDF]

				B. Venho, S. Voutilainen, V.-P. Valkonen, J. Virtanen, T. A Lakka, T. H Rissanen, M.-L. Ovaskainen, M. Laitinen, and J. T Salonen Arginine intake, blood pressure, and the incidence of acute coronary events in men: the Kuopio Ischaemic Heart Disease Risk Factor Study Am. J. Clinical Nutrition, August 1, 2002; 76(2): 359 - 364. [Abstract] [Full Text] [PDF]

				E.J.M. Feskens, C M. Oomen, E. Hogendoorn, A. Menotti, and D. Kromhout Arginine intake and 25-year CHD mortality: the Seven Countries Study Eur. Heart J., April 1, 2001; 22(7): 611 - 612. [PDF]

				A. A Brown and F. B Hu Dietary modulation of endothelial function: implications for cardiovascular disease Am. J. Clinical Nutrition, April 1, 2001; 73(4): 673 - 686. [Abstract] [Full Text] [PDF]